Deficiency of C-reactive protein or human C-reactive protein transgenic treatment aggravates influenza A infection in mice

C-reactive protein (CRP) has been shown to be a potential candidate target in the immunotherapy of severe influenza A infection. However, it is unclear on the pathogenesis associated with CRP in influenza infections. Here, we used influenza A H1N1 CA04 to infect human CRP transgenic mice (KI), CRP k...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhuohan, Gao, Yongjun, Li, Li, Luo, Junhao, Gao, Rongbao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584053/
https://www.ncbi.nlm.nih.gov/pubmed/36275680
http://dx.doi.org/10.3389/fimmu.2022.1028458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584053/
https://www.ncbi.nlm.nih.gov/pubmed/36275680
http://dx.doi.org/10.3389/fimmu.2022.1028458

Ejemplares similares